FDA leadership in flux, but core operations remain stable, former FDA staff say

With Makary’s resignation and other senior departures, there is volatility at the top of the FDA, but long-serving staff are maintaining continuity, experts say. With Makary’s resignation and other senior departures, there is volatility at the top of the FDA, but long-serving staff are maintaining continuity, experts say. The panel session on the FDA at OCT East Coast. Credit: Arena International / Brandon Reynolds At a time when there is a significant void at the top of the US Food and Drug Administration (FDA), experts have said that the trenches remain stable. While Arena International’s Outsourcing in Clinical Trials (OCT)…

Source: Clinical Trials Arena